4th international workshop • the precision medicine in profiling the patients with autoimmune disease: regarding therapy

Congresso a Roma (Lazio) per Medico chirurgo: 4th international workshop • the precision medicine in profiling the patients with autoimmune disease: regarding therapy

Attività formativa per:
Discipline di riferimento:Discipline di riferimento:Discipline di riferimento:
Località di svolgimento:Località di svolgimento:
Mese inizio corso: 
Descrizione del congresso
3 - documentazione clinica. Percorsi clinico-assistenziali diagnostici e riabilitativi, profili di assistenza - profili di cura.
Specifiche evento
Acquisizione competenze di processo:Autoimmune rheumatic diseases are conditions arising from an abnormal immune system activation and characterised by multi-visceral involvement. although many progresses have been done in managing these patients, clinical remission may be reached in less than 50% of patients and a precision medicine is still far away. The overarching aim of this workshop is to understand if stratification of patients, enrolled in trials designed to assess the efficacy of specific drugs or spontaneous studies may improve the knowledge about the therapeutic response and patients satisfaction. Seven immune-mediated diseases will be evaluated: rheumatoid arthritis, systemic lupus erythematosus, primary sjogren’s syndrome, systemic sclerosis, spondyloarthritis, adult-onset still’s disease. The methodology of this meeting is delphi technique-based aimed at producing, starting from the results of a systematic review of available literature, a set of statements summarising the consensus among the experts.
Informazioni
Data:17/02/2023 - 18/02/2023
Comune:Roma
Azienda/Ente formativo:Associazione Sinapsy - Soluzioni E Servizi Integrati
Luogo di svolgimento:Starhotels Metropole
Indirizzo:Via Principe Amedeo,
Crediti assegnati:7
Durata del corso (in ore):7
Quota di partecipazione:0 €
Richiedi Informazioni
X

Richiedi informazioni sul corso

4th international workshop • the precision medicine in profiling the patients with autoimmune disease: regarding therapy